News
The start-up aims to use AI to drastically reduce the time and money it takes to develop new drugs. View on euronews ...
Artificial intelligence (AI) helped develop Pirelli's tires of the future, its new-generation P Zero product line, in record ...
Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...
AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.
Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...
16h
Free Malaysia Today on MSNFirst AI-generated drugs may reach market by 2030, says Insilico CEOThe pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
3d
GlobalData on MSNPharma’s AI prospects get nudged into the future with EU’s AI actExperts predict growing pains as the life sciences sector moves to adapt to the EU AI Act. The EU Artificial Intelligence (AI ...
SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...
7d
Zacks.com on MSNRecursion Pharmaceuticals Plunges 22% in May: How to Play the StockDespite the current downward trend of RXRX, one should retain the stock for long-term gains due to the significant potential ...
Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results